Immune Modulation From Trichuris Suis
NCT03079700 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2017-03-14
Summary
Mucosal immunology during helminth infection
Conditions
- Crohn Disease
- Ulcerative Colitis
- Intestinal Helminthiasis
Interventions
- BIOLOGICAL
-
Trichuris suis eggs
Live eggs from swine whipworm, Trichuris suis
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-08-01
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
More Related Trials
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173 ·Status: RECRUITING ·Phase: NA
-
CD Patients Immune Status Evaluation
NCT04135482 ·Status: COMPLETED
-
A Study on the Associations of Toll-like Receptor 5 Gene Polymorphisms With Crohn's Disease in Chinese Patients
NCT07035678 ·Status: COMPLETED
-
Treg Immunotherapy in Crohn's Disease
NCT03185000 ·Status: UNKNOWN ·Phase: PHASE1
-
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
NCT00790543 ·Status: COMPLETED
-
The Innate Immune System and Inflammatory Bowel Disease
NCT00516776 ·Status: COMPLETED
-
Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease
NCT07258641 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
NCT00655733 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of the Fecal Flora Transplantation on Crohn's Disease
NCT02097797 ·Status: COMPLETED ·Phase: NA
-
Mucosal Innate Immune Activation in Chronic Intestinal Disorders
NCT03529318 ·Status: WITHDRAWN
-
A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
NCT00055523 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Transplant for Crohn's Disease
NCT03078803 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy
NCT00851565 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Inflammatory Bowel Disease Progression
NCT06756100 ·Status: RECRUITING
-
Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis
NCT01418131 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients
NCT01341808 ·Status: COMPLETED ·Phase: PHASE4
-
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
NCT00707512 ·Status: TERMINATED
-
Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
NCT00409617 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Different Dietary IgGs on the Pathogenesis of IBD
NCT03885479 ·Status: UNKNOWN
-
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
NCT06051253 ·Status: RECRUITING ·Phase: PHASE4
-
Intestinal Response Patterns to Microbial Signals
NCT03872622 ·Status: COMPLETED ·Phase: NA
-
Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease
NCT03623932 ·Status: UNKNOWN ·Phase: NA
-
Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases
NCT02179372 ·Status: COMPLETED ·Phase: NA
-
The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease
NCT02453607 ·Status: UNKNOWN